Cardiogenic shock in acute coronary syndrome.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Medical Science Monitor

• Publication date

  2009-02-21

• Fields of study

  Medicine

• Identifiers
  PMID 19247258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experience with over 1000 Implanted Ventricular Assist Devices

  2008cited by this paper
• Effect of prolonged intra-aortic balloon pumping in patients with cardiogenic shock following acute myocardial infarction.

  2007cited by this paper
• Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances)

  2006cited by this paper
• Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.

  2006cited by this paper
• Ventricular unloading with a miniature axial flow pump in combination with extracorporeal membrane oxygenation

  2006cited by this paper
• Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.

  2005cited by this paper
• Predictors of outcome after percutaneous treatment for cardiogenic shock

  2005cited by this paper
• Diabetes mellitus and cardiogenic shock in acute myocardial infarction

  2005cited by this paper
• Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?

  2005cited by this paper
• Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention

  2005cited by this paper
• Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS Trial

  2005cited by this paper
• Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials.

  2005cited by this paper
• Factors Affecting the Management of Outcome in Elderly Patients with Acute Myocardial Infarction Particularly with Regard to Reperfusion

  2005cited by this paper
• Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump.

  2005cited by this paper
• Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis).

  2005cited by this paper
• Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

  2005cited by this paper
• Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation

  2005cited by this paper
• Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines?

  2005cited by this paper
• Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry).

  2005cited by this paper
• Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.

  2005cited by this paper
• Recent developments in cardiac output determination by bioimpedance: comparison with invasive cardiac output and potential cardiovascular applications

  2004cited by this paper
• Impella recover 100 microaxial left ventricular assist device: the Niguarda experience.

  2004cited by this paper
• Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).

  2004cited by this paper
• Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery

  2004cited by this paper
• Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction.

  2004cited by this paper
• Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry.

  2004cited by this paper
• Intraaortic balloon pumping improves hemodynamics and right ventricular efficiency in acute ischemic right ventricular failure.

  2004cited by this paper
• Widespread Myocardial Inflammation and Infarct-Related Artery Patency

  2004cited by this paper
• Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series.

  2004cited by this paper
• Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis.

  2004cited by this paper
• Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization.

  2004cited by this paper
• Role of the Abiomed BVS 5000 Device for Short-Term Support and Bridge to Transplantation

  2004cited by this paper
• Management strategies for cardiogenic shock

  2004cited by this paper
• Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.

  2003cited by this paper
• Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry.

  2003cited by this paper
• Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.

  2003cited by this paper
• Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial

  2003cited by this paper
• Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial

  2003cited by this paper
• Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock

  2003cited by this paper
• Effect of intraaortic balloon pumping on left ventricular function in patients with persistent ST segment elevation after revascularization for acute myocardial infarction.

  2003cited by this paper
• Right ventricular involvement in myocardial infarction and cardiogenic shock.

  2003cited by this paper
• LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study.

  2003cited by this paper
• Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry.

  2003cited by this paper
• Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.

  2003cited by this paper
• ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca

  2003cited by this paper
• Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock.

  2003cited by this paper
• Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development.

  2003cited by this paper
• Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction.

  2002cited by this paper
• Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?

  2002cited by this paper
• Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

  2002cited by this paper
• Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction.

  2002cited by this paper
• The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.

  2001cited by this paper
• Revascularization for cardiogenic shock.

  2001cited by this paper
• One-year survival following early revascularization for cardiogenic shock.

  2001cited by this paper
• [Elective primary angioplasty in cardiogenic shock: results from a single center].

  2001cited by this paper
• Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

  2001cited by this paper
• Outcomes and early revascularization for patients > or = 65 years of age with cardiogenic shock.

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Expression of Inducible Nitric Oxide Synthase Depresses &bgr;-Adrenergic–Stimulated Calcium Release From the Sarcoplasmic Reticulum in Intact Ventricular Myocytes

  2001cited by this paper
• Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction.

  2001cited by this paper
• Catecholamines induce IL-10 release in patients suffering from acute myocardial infarction by transactivating its promoter in monocytic but not in T-cells

  2000cited by this paper
• Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

  2000cited by this paper
• Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation.

  2000cited by this paper
• Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

  2000cited by this paper
• Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?

  2000cited by this paper
• Lack of progress in cardiogenic shock: lessons from the GUSTO trials.

  2000cited by this paper
• The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

  2000cited by this paper
• Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

  2000cited by this paper
• Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry.

  2000cited by this paper
• Effect of early revascularization on mortality from cardiogenic shock complicating acute myocardial infarction in California.

  2000cited by this paper
• Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.

  2000cited by this paper
• The role of neutrophils in myocardial ischemia-reperfusion injury.

  1999cited by this paper
• One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial.

  1999cited by this paper
• Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation.

  1999cited by this paper
• Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

  1999cited by this paper
• Cardiogenic Shock

  1999cited by this paper
• A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH.

  1999cited by this paper
• Temporal trends in cardiogenic shock complicating acute myocardial infarction.

  1999cited by this paper
• Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.

  1999cited by this paper
• Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.

  1999cited by this paper
• Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.

  1998cited by this paper
• Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival.

  1998cited by this paper
• A comparison of reteplase with alteplase for acute myocardial infarction.

  1998cited by this paper
• Why myocardial stunning is clinically important

  1998cited by this paper
• Effect of reperfusion on biventricular function and survival after right ventricular infarction.

  1998cited by this paper
• Progression of myocardial necrosis during reperfusion of ischemic myocardium.

  1998cited by this paper
• Effect of a mechanical vs a pharmacologic increase in aortic pressure on coronary blood flow and thrombolysis induced by IV administration of a thrombolytic agent.

  1997cited by this paper
• Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial.

  1997cited by this paper
• Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

  1997cited by this paper
• Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.

  1997cited by this paper
• Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock.

  1997cited by this paper
• Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators.

  1995cited by this paper
• Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.

  1995cited by this paper
• Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

  1995cited by this paper
• Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.

  1994cited by this paper
• Right ventricular infarction.

  1994cited by this paper
• Mechanisms of beta adrenoceptor desensitisation in the failing human heart.

  1994cited by this paper
• Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital.

  1994cited by this paper
• Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group.

  1993cited by this paper

• Changes in Speckle Tracking Echocardiography Values of the Descending Thoracic Aorta with Rising Positive End-Expiratory Pressure Levels

  2025cites this paper
• Analysis of the Financial Impact of Using Cangrelor on the Safety and Efficacy Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Whom Oral Therapy with P2Y12 Inhibitors is Not Feasible or Desirable, in Spain

  2021cites this paper
• CEOR_A_290377 77..87

  2021cites this paper
• Ischemic Versus Non-Ischemic (Neurogenic) Myocardial Contractility Impairment in Acute Coronary Syndromes: Prevalence and Impact on Left Ventricular Systolic Function Recovery

  2018cites this paper
• Factors Associated with In-hospital Mortality in Patients with Acute Coronary Syndrome

  2015cites this paper
• Прогностическая модель выявления осложнений у пациентов с острым коронарным синдромом

  2012cites this paper
• Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

  2012cites this paper
• Cardiogenic shock: management of right ventricular infarction shock.

  2012cites this paper
• Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock

  2012cites this paper
• Acute myocardial infarction and cardiogenic shock

  2012cites this paper
• Heart Failure After Myocardial Infarction: Clinical Implications and Treatment

  2011cites this paper
• Use of Multinational Registries to Assess and Compare Outcomes of Patients with an Acute Coronary Syndrome: A Dissertation

  2011cites this paper
• Ischaemic cardiogenic shock

  2010cites this paper
• Efficacy and safety of continuous hemodiafiltration for acute decompensated heart failure.

  2010cites this paper
• Emerging drugs for acute myocardial infarction

  2010cites this paper
• Left atrial and left atrial appendage systolic function in patients with post-myocardial distal blocks

  2010cites this paper